Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
925
-
Total 13F shares, excl. options
-
235,807,146
-
Shares change
-
+161,294
-
Total reported value, excl. options
-
$20,287,989,287
-
Value change
-
+$5,952,062
-
Put/Call ratio
-
158%
-
Number of buys
-
372
-
Number of sells
-
-394
-
Price
-
$86.04
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2015
1,015 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2015.
NOVARTIS AG - Ordinary Shares (NVS) has 925 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 235,807,146 shares
of 2,181,288,547 outstanding shares and own 11% of the company stock.
Largest 10 shareholders include Dodge & Cox (45,107,085 shares), PRIMECAP MANAGEMENT CO/CA/ (20,768,108 shares), FRANKLIN RESOURCES INC (9,803,119 shares), BROWN BROTHERS HARRIMAN & CO (8,748,494 shares), WELLS FARGO & COMPANY/MN (7,394,650 shares), Fisher Asset Management, LLC (6,188,893 shares), BANK OF AMERICA CORP /DE/ (5,569,642 shares), UBS Group AG (4,908,204 shares), LOOMIS SAYLES & CO L P (4,833,976 shares), and INSTITUTIONAL CAPITAL LLC (4,613,017 shares).
This table shows the top 925 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.